| Literature DB >> 31496900 |
Satibi Satibi1, M Rifqi Rokhman1, Hardika Aditama1.
Abstract
BACKGROUND: There have been no existing performance indicators to measure the overall quality of pharmacy services, including the aspects of drug management and clinical pharmacy services, at primary health centres in Indonesia. This study aimed to obtain these indicators based on a consensus of experts.Entities:
Keywords: indicators; modified Delphi method; pharmacy service quality; primary health centre
Year: 2019 PMID: 31496900 PMCID: PMC6719888 DOI: 10.21315/mjms2019.26.4.13
Source DB: PubMed Journal: Malays J Med Sci ISSN: 1394-195X
Distribution of expert panel
| Category | Number of persons invited | Agreed to participate | Completed Round 1 | Completed Round 2 | Completed Round 3 |
|---|---|---|---|---|---|
| Chairperson of the province health service quality agency | 1 | 1 | 0 | 0 | 0 |
| Representative of the regency health office | 3 | 3 | 3 | 3 | 3 |
| Pharmacist practitioners at primary health centres | 12 | 12 | 12 | 12 | 9 |
|
| |||||
| Total | 16 | 16 | 15 | 15 | 12 |
Characteristics of expert panel
| Category | Information | Number, |
|---|---|---|
| Profession | Regency-level health officer | 3 (20.0) |
| Pharmacist practitioners at primary health centres | 12 (80.0) | |
| Sex | Male | 2 (13.3) |
| Female | 13 (86.7) | |
| Age | 20–30 years old | 2 (13.3) |
| 30–40 years old | 9 (60.0) | |
| 40–50 years old | 4 (26.7) | |
| Region | Yogyakarta city | 5 (33.3) |
| Sleman Regency | 5 (33.3) | |
| Bantul Regency | 5 (33.3) | |
| Practice experience | 3–5 years | 2 (13.3) |
| > 5–10 years | 7 (46.7) | |
| > 10–15 years | 4 (26.7) | |
| > 15–20 years | 2 (13.3) |
Indicators omitted for Round 2
| Indicator | Mean | IQR | Reason |
|---|---|---|---|
| Frequency of procurement of each drug item per year | 2.85 | 2 | At the primary health centres, there was a standard operating procedure in which procurement was carried out for each month so that this indicator was not relevant. |
| Frequency of incomplete letters of order | 3.17 | 2 | To make an order, the primary health centres wrote an order letter directed to the Regency Pharmacy Installation. If the order letter was incomplete, it would not be processed. This event was also very rare. |
Consensus indicators of drug management
| No. | Indicator | Round 1 | Round 2 | Round 3 | |||
|---|---|---|---|---|---|---|---|
| A. Drug selection | Mean | IQR | Mean | IQR | Mean | IQR | |
| 1 | Propose new drugs to be listed or delisted from formulary | 5.21 | 1 | 6.09 | 0 | 6.00 | 0.5 |
| B. Drug planning | |||||||
| 2 | Suitability of drug item with the national formulary | 6.36 | 1 | 6.42 | 1 | 6.42 | 1 |
| 3 | Suitability of drug items with disease patterns | 3.64 | 3 | 6.00 | 1 | 6.00 | 1 |
| 4 | Adequate funds to fulfil out-of-stock drugs | 4.93 | 2 | 5.88 | 0.5 | 5.33 | 1 |
| 5 | Planning accuracy | 5.57 | 0 | 6.27 | 0.5 | 6.25 | 1 |
| C. Drug order and receipt | |||||||
| 6 | Suitability of the number of drug items requested | 5.69 | 0 | 5.83 | 1 | 6.00 | 1 |
| 7 | Suitability of the number of drug items received | 4.69 | 4 | 5.92 | 1 | 6.33 | 1 |
| D. Drug storage | |||||||
| 8 | Drug storage according to dosage form | 6.29 | 0.75 | 6.58 | 1 | 6.33 | 1 |
| 9 | Drug storage according to temperature | 6.14 | 0.75 | 6.58 | 1 | 6.67 | 1 |
| 10 | Narcotics storage according to regulations | 6.15 | 1 | 6.58 | 1 | 6.75 | 0.25 |
| 11 | Drug storage is not used for storing other items that cause contamination | 6.21 | 1 | 6.08 | 1 | 6.67 | 1 |
| 12 | Drug arrangement follows FEFO method | 6.00 | 1 | 6.50 | 0.25 | 6.83 | 0 |
| 13 | High-alert drug storage | 5.64 | 0 | 6.33 | 1 | 6.67 | 1 |
| 14 | LASA drug storage | 5.71 | 0 | 6.58 | 1 | 6.58 | 1 |
| 15 | Storage of drugs removed from the primary packaging | 4.50 | 2.75 | 6.25 | 1 | 5.83 | 1.25 |
| E. Drug distribution | |||||||
| 16 | Accuracy of the number of drugs distributed to pharmaceutical service sub-unit | - | - | 5.75 | 1.25 | 5.83 | 0.25 |
| F. Drug controls | |||||||
| 17 | Inventory turnover ratio (ITOR) | 3.21 | 0.75 | 4.73 | 3 | 5.92 | 0.5 |
| 18 | Availability level of drugs (month units) | 5.14 | 0 | 5.83 | 0 | 6.08 | 0 |
| 19 | Out-of-stock drug items (< 1 month) | 5.36 | 0.75 | 6.17 | 0.25 | 6.00 | 0.5 |
| 20 | Shortage inventory of drug items (1–< 12 months) | 4.38 | 3 | 6.00 | 0.25 | 5.92 | 1.25 |
| 21 | Adequate inventory of drug items (12–18 months) | 4.29 | 3.75 | 5.75 | 0 | 6.08 | 2 |
| 22 | Overstock dug items (> 18 months) | 4.07 | 3.75 | 5.45 | 1 | 5.83 | 1 |
| 23 | Not prescribed drug items or dead stock (> 3 months) | - | - | - | - | 5.92 | 0.25 |
| 24 | Values of expired and defective drugs | 5.23 | 0 | 5.75 | 1.5 | 6.42 | 1 |
| G. Recording, reporting and archiving | |||||||
| 25 | Accuracy of the physical amount of the drug with the amount on the stock cards or computer | 6.00 | 0 | 6.25 | 1 | 6.42 | 1 |
| H. Drug monitoring and evaluation | |||||||
| 26 | Periodic evaluation of drug management | 6.07 | 0.75 | 6.17 | 1 | 6.00 | 1.25 |
Note:
Indicator has not reached consensus
FEFO: First expired, first out
LASA: Look-alike, sound-alike
Consensus indicators of clinical pharmacy service
| No. | Indicator | Round 1 | Round 2 | Round 3 | |||
|---|---|---|---|---|---|---|---|
| A. Assessing and prescribing | Mean | IQR | Mean | IQR | Mean | IQR | |
| 1 | Prescription screening | - | - | 6.17 | 1 | 6.42 | 1 |
| 2 | Labeling for dispensed drugs | 5.86 | 0 | 6.33 | 1 | 6.25 | 1.25 |
| 3 | Providing drug information when delivering drugs to the patients | 6.21 | 0 | 6.50 | 1 | 6.75 | 0 |
| 4 | Service time | 6.07 | 0 | 6.50 | 1 | 6.50 | 1 |
| 5 | Polypharmacy | 5.50 | 1.5 | 6.42 | 1 | 6.33 | 1 |
| B. Drug information services | |||||||
| 6 | Documentation of drug information services | 6.07 | 0.75 | 6.18 | 1 | 6.08 | 1 |
| C. Counseling | |||||||
| 7 | Providing patient counseling | 3.75 | 2.25 | 6.27 | 1 | 5.92 | 1.25 |
| D. Ward pharmacist services (only for primary health centres that offer inpatient service) | |||||||
| 8 | Documentation of ward pharmacist services | 6.09 | 0.5 | 6.40 | 1 | 6.17 | 1 |
| E. Side effect monitoring | |||||||
| 9 | Documentation of side effect monitoring | 6.00 | 0 | 6.33 | 1 | 6.08 | 0 |
| F. Monitoring of drug therapy | |||||||
| 10 | Documentation of drug therapy monitoring | 5.93 | 0 | 6.00 | 0.25 | 5.67 | 1 |
| G. Evaluation of drug use | |||||||
| 11 | Drug costs per prescription | - | - | - | - | 5.92 | 1.25 |
| 12 | Items per prescription | 6.29 | 1 | 5.83 | 1 | 6.25 | 1.25 |
| 13 | Generic pharmaceutical products | 5.93 | 0.75 | 6.00 | 1 | 5.83 | 1.25 |
| 14 | Antibiotics in non-specific diarrhea | 6.36 | 1 | 6.58 | 1 | 6.58 | 1 |
| 15 | Giving oral rehydration solutions (ORS) and zinc for diarrhea | - | - | - | - | 6.08 | 1 |
| 16 | Antibiotics in acute respiratory infections, non-pneumonia | 6.36 | 1 | 6.58 | 1 | 6.58 | 1 |
| 17 | Avoiding injection for patients with myalgia | 6.07 | 1 | 5.92 | 1 | 6.33 | 1 |
| 18 | Patient compliance | - | - | - | - | 5.67 | 0.25 |
| 19 | Documentation of medication errors | 6.33 | 1 | 6.45 | 1 | 6.58 | 1 |
Note:
Indicator has not reached consensus
Consensus indicators of overall pharmacy performance
| No | Indicator | Round 1 | Round 2 | Round 3 | |||
|---|---|---|---|---|---|---|---|
| Mean | IQR | Mean | IQR | Mean | IQR | ||
| 1 | Patient satisfaction | 6.21 | 0 | 6.25 | 0.25 | 6.33 | 1 |
| 2 | Continuity of patient satisfaction survey | 6.15 | 0 | 6.17 | 0.25 | 6.17 | 1.25 |
Consensus assessment based on mean and IQR in each round
| Indicator | Mean values | Number of indicators | Consensus category based on mean | IQR values | Number of indicators | Consensus category based on IQR | ||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||
| Round 1 | Round 2 | Round 3 | Round 1 | Round 2 | Round 3 | |||||
| Drug management | > 4.9 | 20 | 31 | 26 | High | < 1 | 20 | 26 | 22 | High |
| < 4.9 | 12 | 1 | 2 | Low | 1.01–1.99 | 0 | 3 | 4 | Moderate | |
| > 2 | 12 | 3 | 2 | No | ||||||
| Clinical pharmacy service | > 4.9 | 16 | 18 | 19 | High | < 1 | 15 | 18 | 14 | High |
| < 4.9 | 1 | 0 | 0 | Low | 1.01–1.99 | 1 | 0 | 5 | Moderate | |
| > 2 | 1 | 0 | 0 | No | ||||||
| Overall performance | > 4.9 | 2 | 2 | 2 | High | < 1 | 2 | 2 | 1 | High |
| < 4.9 | 0 | 0 | 0 | Low | 1.01–1.99 | 0 | 0 | 1 | Moderate | |
| > 2 | 0 | 0 | 0 | No | ||||||
Note: In Round 3, two indicators of drug management have not reached consensus